Cargando…
Impact of Enzyme Replacement Therapy on Linear Growth in Korean Patients with Mucopolysaccharidosis Type II (Hunter Syndrome)
Hunter syndrome (or mucopolysaccharidosis type II [MPS II]) arises because of a deficiency in the lysosomal enzyme iduronate-2-sulfatase. Short stature is a prominent and consistent feature in MPS II. Enzyme replacement therapy (ERT) with idursulfase (Elaprase®) or idursulfase beta (Hunterase®) have...
Autores principales: | Cho, Sung Yoon, Huh, Rimm, Chang, Mi Sun, Lee, Jieun, Kwun, Younghee, Maeng, Se Hyun, Kim, Su Jin, Sohn, Young Bae, Park, Sung Won, Kwon, Eun-Kyung, Han, Sun Ju, Jung, Jooyoun, Jin, Dong-Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924006/ https://www.ncbi.nlm.nih.gov/pubmed/24550654 http://dx.doi.org/10.3346/jkms.2014.29.2.254 |
Ejemplares similares
-
Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter Syndrome)
por: Sohn, Young Bae, et al.
Publicado: (2013) -
Clinical, radiologic, and genetic features of Korean patients with Mucopolysaccharidosis IVA
por: Lee, Na Hee, et al.
Publicado: (2012) -
Erratum: Clinical, radiologic, and genetic features of Korean patients with Mucopolysaccharidosis IVA
por: Lee, Na Hee, et al.
Publicado: (2013) -
Birth seasonality in Korean Prader-Willi syndrome with chromosome 15 microdeletion
por: Yang, Aram, et al.
Publicado: (2015) -
Report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I
por: Kwak, Min Jung, et al.
Publicado: (2016)